• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNK COIL-HYDRAULIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNK COIL-HYDRAULIC Back to Search Results
Catalog Number UNK COIL-HYDRAULIC
Device Problem Migration (4003)
Patient Problem Aneurysm (1708)
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No: (b)(4).Literature article "short- and intermediate-term angiographic and clinical outcomes of patients with various grades of coil protrusions following embolization of intracranial aneurysms" reviewed.Abdihalim m, kim sh, maud a, suri mf, tariq n, qureshi ai.Short- and intermediate-term angiographic and clinical outcomes of patients with various grades of coil protrusions following embolization of intracranial aneurysms.Ajnr am j neuroradiol.2011 sep;32(8):1392-8.Doi: 10.3174/ajnr.A2572.Epub 2011 sep 1.Pmid: 21885722; pmcid: pmc7964362.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.
 
Event Description
Literature article "short- and intermediate-term angiographic and clinical outcomes of patients with various grades of coil protrusions following embolization of intracranial aneurysms" reviewed.Abdihalim m, kim sh, maud a, suri mf, tariq n, qureshi ai.Short- and intermediate-term angiographic and clinical outcomes of patients with various grades of coil protrusions following embolization of intracranial aneurysms.Ajnr am j neuroradiol.2011 sep;32(8):1392-8.Doi: 10.3174/ajnr.A2572.Epub 2011 sep 1.Pmid: 21885722; pmcid: pmc7964362."objective and methods: an infrequent occurrence during endovascular treatment is protrusion of detachable coils into the parent lumen with a subsequent thrombosis within in the parent vessel or embolic events.We report the short- and intermediate-term angiographic and clinical outcomes of patients who experience coil or loop protrusions and are managed with medical or additional endovascular treatments.The coil protrusions were identified by retrospective review of 256 consecutive patients treated at 3 centers with endovascular embolizations for intracranial aneurysms and subsequently categorized as grade i when a single loop or coil protruded into the parent vessel lumen less than half the parent artery diameter; grades ii and iii were assigned when a single coil or loop protruded more than half the parent artery diameter, respectively.There were 19 patients with grade i (n = 9), grade ii (n = 4), or grade iii (n = 6) coil protrusions.Patients with active hemodynamic compromise (n = 6) had intracranial stents placed in addition to aspirin (indefinitely) and clopidogrel (range, 1¿12 months; mean, 4.5 months) treatment.The remaining patients were placed on aspirin indefinitely.Complete aneurysm obliteration was achieved in all patients except in 3 in whom near-complete obliteration was achieved.Two patients had intraprocedural aneurysm ruptures, both of whom survived hospitalization.There were 4 deaths (4 ¿21 days), all due to major strokes in different vascular distributions related to vasospasm (unrelated to the coil protrusion).Management of coil protrusions with antiplatelet therapy and placement of stents (in selected patients) appears efficacious in preventing vessel thrombosis.Lot, model and catalog number are not available, but the suspected cerenovus device possibly associated with reported adverse events: envoy guide catheter (cordis, miami lakes, florida).Trufill dcs orbit (cordis).Enterprise stent (cordis).Non-cerenovus devices that were also used in this study: neuroform stents (boston scientific).Gdcs (boston scientific).Hydrocoil (microvention terumo, aliso viejo, california).Microcoil (micrus endovascular, san jose, california).Adverse event(s) and provided interventions: there were 10 patients with major coil/loop protrusions and 9 with minor coil/loop protrusions.All the events were either single coil or loop protrusions.Of the 10 patients - hemodynamic alterations.Attempted multiple times to readjust coils.Intraprocedural aneurysm ruptures during coil/loop protrusions.Managed with anti-coags.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK COIL-HYDRAULIC
Type of Device
COIL-HYDRAULIC
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN & SHURTLEFF, INC. (JUAREZ)
circuito interior norte #1820
parque industrial salvarcar
juarez chihuahua 32574
MX   32574
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
9497898687
MDR Report Key12566341
MDR Text Key278092106
Report Number3008114965-2021-00489
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123560
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK COIL-HYDRAULIC
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/06/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-